What question did this study set out to answer?

To evaluate the prognostic value of the Charlson Comorbidity Index in predicting outcomes for patients undergoing CAR-T therapy for diffuse large B-cell lymphoma.

December 8, 2025BloodOpen Access

Assessing the utility of the charlson comorbidity index in predicting outcomes of CAR-T therapy in patients with diffuse large B-cell lymphoma

View Full Paper

Ask AI

Bookmark

Authors

ASAbdulkader ShaarUniversity of Miami

Discussion

Member takes

Implication

Retrospective analysis associates higher comorbidity burden with increased mortality and complications in DLBCL CAR-T patients, indicating a need for better risk assessment.

Key Points

To evaluate the prognostic value of the Charlson Comorbidity Index in predicting outcomes for patients undergoing CAR-T therapy for diffuse large B-cell lymphoma.
Weighted retrospective analysis of 4,385 adult hospitalizations for CAR-T therapy using National Inpatient Sample data.
Patients were stratified by Charlson Comorbidity Index scores into groups: 2, 3, and ≥4.
Primary outcome measured was in-hospital mortality; secondary outcomes included length of stay and inpatient complications.
In-hospital mortality rates increased with higher CCI scores: 2.29% for CCI 2, 5.34% for CCI 3, and 5.71% for CCI ≥4.
Longer hospitalizations were associated with higher CCI scores, with increases of up to 6.26 days for the highest CCI group.
Complications such as acute kidney injury and the need for mechanical ventilation were notably higher in patients with elevated CCI scores.

Cite This Study

Abdulkader Shaar (2025) studied this question.

synapsesocial.com/papers/69362f694fa91c937236df64 https://doi.org/10.1182/blood-2025-3727

View Full Paper

Ask AI

Bookmark

Implication

Retrospective analysis associates higher comorbidity burden with increased mortality and complications in DLBCL CAR-T patients, indicating a need for better risk assessment.

Assessing the utility of the charlson comorbidity index in predicting outcomes of CAR-T therapy in patients with diffuse large B-cell lymphoma

Discussion

Member takes

Implication

Key Points

Cite This Study

Assessing the utility of the charlson comorbidity index in predicting outcomes of CAR-T therapy in patients with diffuse large B-cell lymphoma

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider